CClinicalTrials.gg
CompletedNCT05631925Updated Dec 7, 2022

Comparison of Two Different Anesthesia Methods in IVF Procedure

A Phase 4 interventional study of propofol bolus and propofol infusion in Oocyte Retrieval, sponsored by Acibadem University. Completed at 1 site in Turkey. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-07.

Sponsored by Acibadem University · Phase 4, Interventional, and Health services research

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled May 2022, registered Nov 2022).
Phase
Phase 4
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

In this study; during the oocyte retrieval procedure, it was aimed to compare two different general anesthesia methods, in which propofol was administered as infusion according to the patient's Bispectral index system (BIS) value or in bolus doses according to the patient's clinic.The hypothesis of the study; during the oocyte retrieval process, when propofol is administered as an infusion and accompanied by BIS monitoring, adequate anesthesia level will be achieved with less amount of bolus doses according to the clinical condition of the patient.

Read the detailed description

130 patients over the age of 18, ASA I-II, who underwent oocyte retrieval for IVF treatment were included in the study. The patients divided into two groups. In induction, 2mg/kg fentanyl, 40mg lidocaine and 2mg/kg propofol administered to all patients. Patients in group 1; propofol added in bolus doses of 0.5mg/kg. Doses determined according to the clinical condition of the patient. Patients in group 2; propofol administered as 10mg/kg/hour infusion. The infusion dose adjusted so that the Bispectral index (BIS) is in the range of 40-60.

02

Conditions studied

  • Oocyte Retrieval
03

In context

Lead sponsor

Acibadem University is the lead sponsor of 210 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Over 18 years
  • ASA I-II
  • Patients who underwent oocyte retrieval for IVF treatment

Exclusion criteria

Exclusion Criteria:

  1. The patient does not want to participate
  2. ASA > II patients
  3. Patients under 18 years of age
  4. Patients who are allergic to the drugs used
  5. Patients with mental illness
  6. Patients with alcohol or substance addiction
05

Study design

Phase
Phase 4
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
130 participants (actual)

Study arms

  • Active comparator
    Group bolus

    Propofol will be administered in bolus doses of 0.5mg/kg. Doses will be determined according to the clinical condition of the patient.

    Drug: propofol bolus

  • Active comparator
    Group infusion

    Propofol will be administered as 10mg/kg/hour infusion. The infusion dose will be adjusted so that the Bispectral index (BIS) is in the range of 40-60.

    Drug: propofol infusion

Interventions

  • Drugpropofol bolus

    Propofol will be added in bolus doses of 0.5mg/kg.

  • Drugpropofol infusion

    Propofol will be administered as 10mg/kg/hour infusion.

06

What researchers measure

Primary outcomes

  1. Propofol

    The total amount of Propofol (mg) administered during the procedure

    Time frame: up to 1 hour

Secondary outcomes

  1. Observer's assessment of sedation scale (OSS)

    Time to reach 5 on the observer's assessment of sedation scale of the patients

    Time frame: up to 1 hour

  2. (Post Anesthetic Discharge Scoring System) PADSS

    Time of patients to reach PADSS ≥ 9 (Min:0 and Max: 10) PADSS ≥ 9 is suitable for discharge of the patient

    Time frame: up to 6 hour

  3. (Satisfaction of patients) STF 1

    Patient satisfaction (The scale is in the range of 1-4. 1: the best)

    Time frame: up to 6 hour

  4. (Satisfaction of gynecologist) STF 2

    Satisfaction of the doctor performing the procedure(The scale is in the range of 1-4. 1: the best)

    Time frame: up to 1 hour

07

Study locations

1 site
  • Acibadem Kozyatagi Hastanesi
    Istanbul, 34742, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05631925
Lead sponsor
Acibadem University
Responsible party
Sevgi Bilgen (Associate Professor, Acibadem University) — Principal investigator
First posted
Nov 30, 2022
Start date
May 27, 2022
Primary completion
Aug 17, 2022
Completion
Aug 17, 2022
Last update
Dec 7, 2022

Study contacts

Sevgi Bilgen
study chair · Acibadem University, Acibadem Kozyatagi Hastanesi

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion